Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
IRVINE, Calif.--(BUSINESS WIRE)--Jul 6, 2007 - Cobalis Corp.(OTCBB:CLSC), a pharmaceutical development company specializing inanti-allergy medications, today reported preliminary top-lineresults from two Phase III clinical trials for its drugPreHistin(TM) in patients with moderate to moderately severeseasonal allergic rhinitis, commonly known as hay fever. The trialsshowed very low symptom...Cobalis Expects to Report Phase III Top-Line Results in May
IRVINE, Calif.--(BUSINESS WIRE)--Apr 30, 2007 - Cobalis Corp. (OTCBB: CLSC), a pharmaceutical development company specializing inanti-allergy medications, today announced it has been informed byits independent contract research organization that it would needmore time to combine Cobalis' three locked data bases into a singledatabase before un-blinding and conducting the statistical analysis...